M3 Advisory Group, LLC Biogen Inc. Transaction History

M3 Advisory Group, LLC

$121 Billion
Q2 2024

A detailed history of M3 Advisory Group, LLC transactions in Biogen Inc. stock. As of the latest transaction made, M3 Advisory Group, LLC holds 885 shares of BIIB stock, worth $173,132. This represents 0.17% of its overall portfolio holdings.

Number of Shares

885

Holding current value

$173,132

% of portfolio

0.17%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Jul 19, 2024	BUY	$190.52 - $236.72 $168,610 - $209,497	885 New	885 $205 Million
Q4 2023 Mar 19, 2024	BUY	$222.59 - $267.94 $188,756 - $227,213	848 New	848 $219 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$3.25 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$3.2 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.84 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.39 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$1.11 Billion
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M3 Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on M3 Advisory Group, LLC with notifications on news.

Account